Waldo Belloso

4.8k total citations · 2 hit papers
47 papers, 2.7k citations indexed

About

Waldo Belloso is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Waldo Belloso has authored 47 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 14 papers in Virology and 14 papers in Emergency Medicine. Recurrent topics in Waldo Belloso's work include HIV/AIDS drug development and treatment (20 papers), HIV/AIDS Research and Interventions (16 papers) and HIV-related health complications and treatments (14 papers). Waldo Belloso is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), HIV/AIDS Research and Interventions (16 papers) and HIV-related health complications and treatments (14 papers). Waldo Belloso collaborates with scholars based in Argentina, United States and Australia. Waldo Belloso's co-authors include Jens Lundgren, Fraser Drummond, H. Clifford Lane, Daniel E. Nixon, Bruno Ledergerber, Lewis H. Kuller, Russell P. Tracy, Nicholas I. Paton, Jacqueline Neuhaus and James D. Neaton and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Waldo Belloso

46 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

2008 1.2k citations Lewis H. Kuller, Russell P. Tracy et al. PLoS Medicine profile →
Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

2012 419 citations Daniel Duprez, Jacqueline Neuhaus et al. PLoS ONE profile →

Peers

Waldo Belloso

VIROL

EPIDE

IMMUN

Jacqueline Neuhaus United States

Stéphane De Wit Belgium

Signe Westring Worm Denmark

Stéphane De Wit Belgium

Lene Ryom Denmark

Chris T. Longenecker United States

Giuseppe Vittorio De Socio Italy

Nina Friis‐Møller Denmark

M Pang China

María Larrousse Spain

Jacqueline Neuhaus United States

Waldo Belloso

2.8k ×1.6

2.2k ×1.6

1.9k ×1.5

VIROL

981 ×1.9

EPIDE

370 ×1.5

IMMUN

Citations per year, relative to Waldo Belloso Waldo Belloso (= 1×) peers Jacqueline Neuhaus

Countries citing papers authored by Waldo Belloso

Since Specialization

Citations

This map shows the geographic impact of Waldo Belloso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldo Belloso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldo Belloso more than expected).

Fields of papers citing papers by Waldo Belloso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waldo Belloso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldo Belloso. The network helps show where Waldo Belloso may publish in the future.

Co-authorship network of co-authors of Waldo Belloso

This figure shows the co-authorship network connecting the top 25 collaborators of Waldo Belloso. A scholar is included among the top collaborators of Waldo Belloso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waldo Belloso. Waldo Belloso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scibona, Paula, Waldo Belloso, Facundo García‐Bournissen, et al.. (2024). A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti‐Shiga toxin hyperimmune equine F (ab′)₂ fragments in healthy volunteers. British Journal of Clinical Pharmacology. 90(4). 1142–1151. 2 indexed citations

Blumberg, Emily A., Gary Collins, Jo‐Anne H. Young, et al.. (2021). Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study. Transplant Infectious Disease. 24(1). 4 indexed citations

Belloso, Waldo. (2020). On Innovation. Therapeutic Innovation & Regulatory Science. 54(5). 1068–1075. 8 indexed citations

Vázquez, Carolina, et al.. (2017). Prevalence of thymidylate synthase gene 5'-untranslated region variants in an Argentinean sample. Genetics and Molecular Research. 16(1). 2 indexed citations

Boyd, Mark, Janaki Amin, Patrick Mallon, et al.. (2016). Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. The Lancet HIV. 4(1). e13–e20. 5 indexed citations

Álvarez, Elena, Waldo Belloso, Mark Boyd, et al.. (2016). Which HIV patients should be screened for osteoporosis. Current Opinion in HIV and AIDS. 11(3). 268–276. 18 indexed citations

Scibona, Paula, et al.. (2015). Prevalence of CYP2B6 polymorphisms in Argentinians: the role of genetic testing. Genetics and Molecular Research. 14(4). 16594–16599. 4 indexed citations

Keller, Guillermo Alberto, Paulino Álvarez, Waldo Belloso, et al.. (2015). Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice. Current Drug Safety. 11(1). 86–98. 22 indexed citations

Musso, Carlos G., Waldo Belloso, Paula Scibona, Vincenzo Bellizzi, & Juan F. Macías Núñez. (2015). Impact of renal aging on drug therapy. Postgraduate Medicine. 127(6). 623–629. 10 indexed citations

10.

Scibona, Paula, et al.. (2014). Farmacogenómica cardiovascular. Archivos de cardiología de México. 84(1). 25–31. 1 indexed citations

11.

Martin, Allison, Cecilia L. Moore, Patrick Mallon, et al.. (2013). HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy. PLoS ONE. 8(10). e77138–e77138. 14 indexed citations

12.

Scibona, Paula, et al.. (2012). Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants. Genetics and Molecular Research. 11(1). 70–76. 17 indexed citations

13.

Belloso, Waldo, et al.. (2011). Recurrent Meningitis and Subarachnoid Hemorrhage Due to Salmonella in an HIV+ Patient: Case Report and Mini-Review of the Literature. The Open AIDS Journal. 5(1). 62–66. 2 indexed citations

14.

Lifson, Alan R., Waldo Belloso, Richard T. Davey, et al.. (2010). Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials. HIV Clinical Trials. 11(4). 205–219. 35 indexed citations

15.

Puls, Rebekah, Preeyaporn Srasuebkul, Kathy Petoumenos, et al.. (2010). Efavirenz versus Boosted Atazanavir or Zidovudine and Abacavir in Antiretroviral Treatment–Naive, HIV‐Infected Subjects: Week 48 Data from the Altair Study. Clinical Infectious Diseases. 51(7). 855–864. 46 indexed citations

16.

Kuller, Lewis H., Russell P. Tracy, Waldo Belloso, et al.. (2008). Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. PLoS Medicine. 5(10). e203–e203. 1231 indexed citations breakdown →

17.

Belloso, Waldo, et al.. (2003). Agreement Analysis of Variables Involved in Lipodystrophy Syndrome Definition in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(1). 104–111. 17 indexed citations

18.

Masciotra, Silvina, Waldo Belloso, Liliana Clara, et al.. (2000). Sequence Note: Evidence of a High Frequency of HIV-1 Subtype F Infections in a Heterosexual Population in Buenos Aires, Argentina. AIDS Research and Human Retroviruses. 16(10). 1007–1014. 27 indexed citations

19.

Cahn, Pedro, et al.. (2000). AIDS IN LATIN AMERICA. Infectious Disease Clinics of North America. 14(1). 185–209. 22 indexed citations

20.

Losso, Marcelo, Waldo Belloso, Sean Emery, et al.. (2000). A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin‐2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus–Infected Patients with CD4⁺Cell Counts ⩾350/mm³. The Journal of Infectious Diseases. 181(5). 1614–1621. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact